BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1

We have previously shown that the breast cancer susceptibility gene, BRCA1, can transcriptionally activate the p27Kip1 promoter. The BRCA1-responsive element was defined as a 35 bp region from position −545 to −511. We next determined that within this region is also a potential binding site for the transcription factor Forkhead box (FOX)A1. RNA and protein analysis as well as immunohistochemistry showed that expression of FOXA1 correlated with the expression of the estrogen receptor in a panel of breast cancer cell lines and tissues. In transient transfection reporter assays, FOXA1 could activate the p27Kip1 promoter. Cotransfection of BRCA1 and FOXA1 resulted in a synergistic activation of the p27Kip1 promoter. Mutation of the FOXA1 DNA-binding site in the p27Kip1 promoter-luciferase construct significantly diminished the activity of FOXA1 alone or in combination with BRCA1. Cotransfection of FOXA1 and BRCA1 resulted in a greater amount of each protein compared to transfection of each expression vector alone. The half-life of FOXA1 was increased when coexpressed with BRCA1. Electrophoretic mobility shift assay analysis demonstrated that FOXA1 could bind to a wild-type oligonucleotide containing the FOXA1 binding site in the p27Kip1 promoter, but this binding was lost upon mutation of this FOXA1 binding site. The protein–DNA binding complex could be supershifted with an antibody directed against FOXA1. The activity of the p27Kip1 promoter as well as FOXA1 expression was reduced in cells treated with BRCA1 siRNA, thus silencing the expression of BRCA1 protein. In summary, we identified a FOXA1 binding site within the BRCA1-responsive element of the p27Kip1 promoter and showed that FOXA1 activated the promoter alone and in conjunction with BRCA1. Furthermore, we identified high expression of FOXA1 in breast cancer cell lines and tissues, discovered a role for BRCA1 in the regulation of p27Kip1 transcription and a possible interaction with BRCA1.

[1]  A. Bowcock,et al.  The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression* , 1998, The Journal of Biological Chemistry.

[2]  Jonathan P. Katz,et al.  Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. , 1999, Genes & development.

[3]  Frank R. Lin,et al.  Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. , 2002, Molecular cell.

[4]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[6]  Thomas M. Jessell,et al.  The winged-helix transcription factor HNF-3β is required for notochord development in the mouse embryo , 1994, Cell.

[7]  C. Cordon-Cardo,et al.  Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. , 1999, Journal of the National Cancer Institute.

[8]  Hui Tian,et al.  BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.

[9]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[10]  Tony Hunter,et al.  Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein* , 2003, The Journal of Biological Chemistry.

[11]  Hongtao Zhang,et al.  BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells , 1998, Oncogene.

[12]  R. Costa,et al.  The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix , 1994, Molecular and cellular biology.

[13]  A. Chumakov,et al.  C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. , 1999, Blood.

[14]  S. Burley,et al.  Binding of the winged‐helix transcription factor HNF3 to a linker histone site on the nucleosome , 1998, The EMBO journal.

[15]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Darnell,et al.  Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. , 1991, Genes & development.

[17]  C. Deng,et al.  Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice , 2001, Oncogene.

[18]  Y. Houvras,et al.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl , 1997, Nature.

[19]  T. Ouchi,et al.  BRCA1 regulates p53-dependent gene expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Futreal,et al.  Novel consensus DNA‐binding sequence for BRCA1 protein complexes , 2003, Molecular carcinogenesis.

[21]  D. Jackson,et al.  Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition , 1993, Molecular and cellular biology.

[22]  Y. Houvras,et al.  BRCA1 Physically and Functionally Interacts with ATF1* , 2000, The Journal of Biological Chemistry.

[23]  C. Woodcock,et al.  Nucleosome positioning by the winged helix transcription factor HNF3. , 1998, Genes & development.

[24]  C. Deng,et al.  BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome , 2002, Cell.

[25]  M. Trivett,et al.  Brca1 inactivation induces p27Kip1-dependent cell cycle arrest and delayed development in the mouse mammary gland , 2004, Oncogene.

[26]  W. Knöchel,et al.  Five years on the wings of fork head , 1996, Mechanisms of Development.

[27]  L. Lim,et al.  Transcription factors in mouse lung development and function. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[28]  Herman Yeger,et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.

[29]  M. Cunningham,et al.  FoxO1a can alter cell cycle progression by regulating the nuclear localization of p27kip in granulosa cells. , 2004, Molecular endocrinology.

[30]  E. Rosen,et al.  Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1 , 2001, Oncogene.

[31]  K. Zaret,et al.  Developmental competence of the gut endoderm: genetic potentiation by GATA and HNF3/fork head proteins. , 1999, Developmental biology.

[32]  M. Stoffel,et al.  Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Burley,et al.  Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 , 1993, Nature.

[34]  M. Barton,et al.  Hepatocyte Nuclear Factor 3 Relieves Chromatin-mediated Repression of the α-Fetoprotein Gene* , 1999, The Journal of Biological Chemistry.

[35]  E. Williamson,et al.  BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1 , 2002, Oncogene.